These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 11526920)

  • 61. Hydroxyethyl starch for resuscitation.
    Haase N; Perner A
    Curr Opin Crit Care; 2013 Aug; 19(4):321-5. PubMed ID: 23743591
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Randomised trials of 6% tetrastarch (hydroxyethyl starch 130/0.4 or 0.42) for severe sepsis reporting mortality: systematic review and meta-analysis.
    Patel A; Waheed U; Brett SJ
    Intensive Care Med; 2013 May; 39(5):811-22. PubMed ID: 23430019
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Should hydroxyethyl starch solutions be totally banned?
    Vincent JL; Kellum JA; Shaw A; Mythen MG
    Crit Care; 2013 Oct; 17(5):193. PubMed ID: 24083341
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Decision of the European Medicines Agency on hydroxyethyl starch : Important step towards therapeutic and legal security].
    Zwissler B; Rossaint R
    Anaesthesist; 2013 Nov; 62(11):869-70. PubMed ID: 24275932
    [No Abstract]   [Full Text] [Related]  

  • 65. The risk of infusing gelatin? Die-hard misconceptions and forgotten (or ignored) truths.
    Pisano A; Landoni G; Bellomo R
    Minerva Anestesiol; 2016 Oct; 82(10):1107-1114. PubMed ID: 27045639
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Osmotic nephrosis in a renal transplant recipient.
    Ebcioglu Z; Cohen DJ; Crew RJ; Hardy MA; Ratner LE; D'Agati VD; Markowitz GS
    Kidney Int; 2006 Nov; 70(10):1873-6. PubMed ID: 16883320
    [No Abstract]   [Full Text] [Related]  

  • 67. Deleterious renal effects of hydroxyethyl starch 130/0.4 and 200/0.5 solutions.
    Davidson IJ
    Eur J Anaesthesiol; 2007 Oct; 24(10):892-3. PubMed ID: 17977101
    [No Abstract]   [Full Text] [Related]  

  • 68. Is 6% tetrastarch 130kDa (hydroxyethyl starch 130/0.4 or 130/0.42) suitable for severe sepsis?
    Patel A; Brett SJ
    Br J Hosp Med (Lond); 2013 Mar; 74(3):178. PubMed ID: 23665793
    [No Abstract]   [Full Text] [Related]  

  • 69. Faulty risk-of-bias assessment in a meta-analysis of hydroxyethyl starch for nonseptic ICU patients.
    Bayer O; Reinhart K
    Crit Care; 2015 Oct; 19():357. PubMed ID: 26446864
    [No Abstract]   [Full Text] [Related]  

  • 70. Concerns over use of hydroxyethyl starch solutions.
    Hartog CS; Natanson C; Sun J; Klein HG; Reinhart K
    BMJ; 2014 Nov; 349():g5981. PubMed ID: 25385352
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Skin tests for diagnosis of hypersensitivity to colloidal plasma substitutes].
    Leynadier F; Wessel F
    Ann Fr Anesth Reanim; 2002 May; 21 Suppl 1():121s-122s. PubMed ID: 12091977
    [No Abstract]   [Full Text] [Related]  

  • 72. Fluid management and risk factors for renal dysfunction in patients with severe sepsis and/or septic shock.
    Muller L; Jaber S; Molinari N; Favier L; Larché J; Motte G; Lazarovici S; Jacques L; Alonso S; Leone M; Constantin JM; Allaouchiche B; Suehs C; Lefrant JY;
    Crit Care; 2012 Feb; 16(1):R34. PubMed ID: 22377234
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Is the use of colloids for fluid replacement harmless in children?
    Saudan S
    Curr Opin Anaesthesiol; 2010 Jun; 23(3):363-7. PubMed ID: 20386439
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Faulty risk-of-bias assessment in a meta-analysis of hydroxyethyl starch for non-septic ICU patients: a rebuttal.
    James M; Joubert I; Michell WL; Nicol A; Navsaria P; Gillespie R
    Crit Care; 2015 Dec; 19():444. PubMed ID: 26699365
    [No Abstract]   [Full Text] [Related]  

  • 75. Concerns about renal safety of HES 130.
    Wiedermann CJ; Joannidis M
    Crit Care; 2013 Aug; 17(4):444. PubMed ID: 23906024
    [No Abstract]   [Full Text] [Related]  

  • 76. Influence of volume therapy with a modern hydroxyethylstarch preparation on kidney function in cardiac surgery patients with compromised renal function: a comparison with human albumin.
    Boldt J; Brosch C; Ducke M; Papsdorf M; Lehmann A
    Crit Care Med; 2007 Dec; 35(12):2740-6. PubMed ID: 17893629
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The relationship of intravenous fluid chloride content to kidney function in patients with severe sepsis or septic shock.
    Guirgis FW; Williams DJ; Hale M; Bajwa AA; Shujaat A; Patel N; Kalynych CJ; Jones AE; Wears RL; Dodani S
    Am J Emerg Med; 2015 Mar; 33(3):439-43. PubMed ID: 25650359
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Renal impact of fluid management with colloids.
    Boldt J
    Eur J Anaesthesiol; 2007 Oct; 24(10):891-2. PubMed ID: 17977100
    [No Abstract]   [Full Text] [Related]  

  • 79. Adverse effects of plasma volume expanders.
    Isbister JP; Fisher MM
    Anaesth Intensive Care; 1980 May; 8(2):145-51. PubMed ID: 6156607
    [No Abstract]   [Full Text] [Related]  

  • 80. [Sideeffects of colloids (author's transl)].
    Messmer K; Ring J; Hedin H; Richter W; Seemann C
    Zentralbl Chir; 1978; 103(15):978-85. PubMed ID: 81575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.